Clinical Nutrition Market Size to Reach USD 55,250.30 Million by 2026 at a CAGR Of 5.3% - Valuates Reports - Seite 2

However, the clinical nutrition market's growth is hampered by a lack of knowledge and strict regulations. 

View Full Report: https://reports.valuates.com/market-reports/ALLI-Manu-1E38/clinical-nu ...

CLINICAL NUTRITION MARKET SHARE ANALYSIS

Based on Administration type, In 2018, the oral category had the largest share, and this is projected to continue the trend during the forecast period. This dominance is attributed to its widespread use by patients due to its ease of use and availability for a variety of diseases.

Based on the application segment, the cancer segment cancer is projected to be the fastest-growing segment during the forecast period. This is due to dietary deficiency caused by multiple cancer therapies such as chemotherapy, hormone therapy, radiation therapy, surgery, immunotherapy, and stem cell transplantation.

By end-user segment, the pediatric segment accounted for the largest share in 2018 and is expected to continue its dominance during the forecast period. The growing concern about malnutrition in pediatric patients worldwide is expected to be a major driver of the pediatric segment's growth in the clinical nutrition market.

Based on region, North America was the leading revenue contributor to the global clinical nutrition market in 2018 and is expected to continue its dominance during the forecast period. On the other hand, Asia-Pacific is expected to experience the fastest CAGR during the forecast period. Dominance of the North American region is due to the upsurge in the number of chronic diseases such as coronary artery disease, ischemic stroke, diabetes, few cancer indications, and an increase in the region's geriatric population. Furthermore, the US government's initiative to encourage full nutrition treatment for cancer patients is expected to further fuel the market.

Inquire For Regional Report: https://reports.valuates.com/request/regional/ALLI-Manu-1E38/Clinical_ ...

KEY MARKET SEGMENTS

By Route Of Administration

• Oral
• Enteral
• Parenteral

By Application

• Cancer
• Neurological Diseases
• Gastrointestinal Disorders
• Metabolic Disorders
• Others

By End User

• Pediatric
• Adults
• Geriatric

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• Spain
• Italy
• UK
• Rest of Europe
• Asia-Pacific
• Japan
• India
• China
• Australia
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

Key players operating in the global clinical nutrition market, which include Abbott Laboratories, B. Braun Melsungen AG, Danone Nutricia, Baxter International Inc., Fresenius SE & Co. KGaA, Perrigo Company Plc, Pfizer Inc., Nestlé S.A, Lonza Ltd., and Hero Nutritionals Inc.